GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Operating Margin %

RetinalGenix Technologies (RetinalGenix Technologies) Operating Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. RetinalGenix Technologies's Operating Income for the three months ended in Mar. 2024 was $-2.15 Mil. RetinalGenix Technologies's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, RetinalGenix Technologies's Operating Margin % for the quarter that ended in Mar. 2024 was 0.00%.

The historical rank and industry rank for RetinalGenix Technologies's Operating Margin % or its related term are showing as below:


RTGN's Operating Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.66
* Ranked among companies with meaningful Operating Margin % only.

RetinalGenix Technologies's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

RetinalGenix Technologies's Operating Income for the three months ended in Mar. 2024 was $-2.15 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.72 Mil.


RetinalGenix Technologies Operating Margin % Historical Data

The historical data trend for RetinalGenix Technologies's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Operating Margin % Chart

RetinalGenix Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Operating Margin %
- - - -

RetinalGenix Technologies Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of RetinalGenix Technologies's Operating Margin %

For the Medical Devices subindustry, RetinalGenix Technologies's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RetinalGenix Technologies's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Operating Margin % distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's Operating Margin % falls into.



RetinalGenix Technologies Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

RetinalGenix Technologies's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-2.087 / 0
= %

RetinalGenix Technologies's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=-2.145 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RetinalGenix Technologies  (OTCPK:RTGN) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


RetinalGenix Technologies Operating Margin % Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.

RetinalGenix Technologies (RetinalGenix Technologies) Headlines